Inhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK rats

European Journal of Pharmacology

Volumn 510, Issue 1-2, 2005, Pages 149-156

  Lameynardie, Stéphane ^a   Chiavaroli, Carlo ^b   Travo, Pierre ^c   Garay, Ricardo P ^d,e   Parés Herbuté, Núria ^a  

^a UNIV MONTPELLIER   (France)

^b Vifor (International) Inc   (Switzerland)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e NONE   (France)

Author keywords

(Rat); Angiogenesis; Calcium dobesilate; Diabetes; VEGF (vascular endothelial cell growth factor)

Indexed keywords

COLLAGEN GEL; DOBESILATE CALCIUM; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; EXPLANT; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 14644395485     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.01.015     Document Type: Article

References (33)

1. L.M. Aiello Perspectives on diabetic retinopathy Am. J. Ophthalmol. 136 2003 122 135
2. L.P. Aiello, R.L. Avery, and P.G. Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N. Engl. J. Med. 331 1994 1480 1487
3. H. Ashino, M. Shimamura, H. Nakajima, M. Dombou, S. Kawanaka, T. Oikawa, T. Iwaguchi, and S. Kawashima Novel function of ascorbic acid as an angiostatic factor Angiogenesis 6 2003 259 269
4. A. Benakis, B. Glasson, C.A. Bouvier, J. Ritschard, B. Krahenbuhl, A. Jung, and H.J. Hachen Metabolism and pharmacokinetics of calcium dobesilate in humans Therapie 29 1974 211 219
5. P. Berthet, J.C. Farine, and J.P. Barras Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy Int. J. Clin. Pract. 53 1999 631 636
6. J. Brunet, J.C. Farine, R.P. Garay, and P. Hannaert In vitro antioxidant properties of calcium dobesilate Fundam. Clin. Pharmacol. 12 1998 205 212
7. J. Brunet, J.C. Farine, R.P. Garay, and P. Hannaert Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat Eur. J. Pharmacol. 358 1998 213 220
8. P.A. Campochiaro Retinal and choroidal neovascularization J. Cell. Physiol. 184 2000 301 310
9. P.A. Campochiaro, and S.F. Hackett Ocular neovascularization: a valuable model system Oncogene 22 2003 6537 6548
10. J. Cao, S. McLeod, C.A. Merges, and G.A. Lutty Choriocapillaris degeneration and related pathologic changes in human diabetic eyes Arch. Ophthalmol. 116 1998 589 597
11. A. Das, W. Fanslow, D. Cerretti, E. Warren, N. Talarico, and P. McGuire Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization Lab. Invest. 83 2003 1637 1645
12. N. Ferrara VEGF: an update on biological and therapeutic aspects Curr. Opin. Biotechnol. 11 2000 617 624
13. R.N. Frank, R.H. Amin, D. Eliott, J.E. Puklin, and G.W. Abrams Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes Am. J. Ophthalmol. 122 1996 393 403
14. A.W. Fryczkowski, B.L. Hodes, and J. Walker Diabetic choroidal and iris vasculature scanning electron microscopy findings Int. Ophthalmol. 13 1989 269 279
15. F.M. Grignolo, M. Musso, P. Borromeo, and F. Sebastini Fluorescence iris angiography in the assessment of calcium dobesilate therapy in the treatment of diabetic microangiopathy Ophthalmologica 178 1979 250 258
16. S. He, M.L. Jin, V. Worpel, and D.R. Hinton A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization Arch. Ophthalmol. 121 2003 1283 1288
17. A.A. Hidayat, and B.S. Fine Diabetic choroidopathy. Light and electron microscopic observations of seven cases Ophthalmology 92 1985 512 522
18. S. Kobayashi, M. Fukuta, H. Kontani, S. Yanagita, and I. Kimura A quantitative assay for angiogenesis of cultured choroidal tissues in streptozotocin-diabetic Wistar and spontaneously diabetic GK rats Jpn. J. Pharmacol. 78 1998 471 478
19. E.B. Leite, M.C. Mota, J.R. de Abreu, and J.G. Cunha-Vaz Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy Int. Ophthalmol. 14 1990 81 88
20. N. Maulik, and D.K. Das Redox signaling in vascular angiogenesis Free Radic. Biol. Med. 33 2002 1047 1060
21. K. Miyamoto, Y. Ogura, H. Nishiwaki, N. Matsuda, Y. Honda, S. Kato, H. Ishida, and Y. Seino Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes Investig. Ophthalmol. Vis. Sci. 37 1996 898 905
22. C.N. Nagineni, W. Samuel, S. Nagineni, K. Pardhasaradhi, B. Wiggert, B. Detrick, and J.J. Hooks Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases J. Cell. Physiol. 197 2003 453 462
23. B. Nemeth, J. Hudomel, and A. Farkas Effect of calcium dobesilate (doxium) on circulatory disorders of the retina with special emphasis on diabetic retinopathy Ophthalmologica 170 1975 434 445
24. R.F. Nicosia, and A. Ottinetti Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro Lab. Invest. 63 1990 115 122
25. H. Ozaki, M.S. Seo, K. Ozaki, H. Yamada, E. Yamada, N. Okamoto, F. Hofmann, J.M. Wood, and P.A. Campochiaro Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization Am. J. Pathol. 156 2000 697 707
26. I. Rota, C. Chiavaroli, R.P. Garay, and P. Hannaert Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats Eur. J. Pharmacol. 495 2004 217 224
27. H. Sone, Y. Kawakami, Y. Okuda, Y. Sekine, S. Honmura, K. Matsuo, T. Segawa, H. Suzuki, and K. Yamashita Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes Diabetologia 40 1997 726 730
28. M.A. Speicher, R.P. Danis, M. Criswell, and L. Pratt Pharmacologic therapy for diabetic retinopathy Expert Opin. Emerg. Drugs 8 2003 239 250
29. M.E. Szabo, D. Haines, E. Garay, C. Chiavaroli, J.C. Farine, P. Hannaert, A. Berta, and R.P. Garay Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina Eur. J. Pharmacol. 428 2001 277 286
30. J.C. Tardif, J. Gregoire, and P.L. L'Allier Prevention of restenosis with antioxidants: mechanisms and implications Am. J. Cardiovasc. Drugs 2 2002 323 334
31. T. Tejerina, and E. Ruiz Calcium dobesilate: pharmacology and future approaches Gen. Pharmacol. 31 1998 357 360
32. B. Vojnikovic Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma Ophthalmic Res. 23 1991 12 20
33. F. Wang, K.G. Rendahl, W.C. Manning, D. Quiroz, M. Coyne, and S.S. Miller AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat Investig. Ophthalmol. Vis. Sci. 44 2003 781 790